Fresh off the first-ever regulatory approval of one of its products, cardiac mapping company CardioInsight Technologies is on the fundraising trail.The Cleveland-based company recently filed regulatory documents, with one indicating it’s raised $1.6 million in convertible debt from 14 investors since May. Another filing shows that the company has raised $7.5 million in equity since [...]

Noninvasive cardiac imaging company CardioInsight Technologies has added another $1 million ahead of an August product launch in Europe.The Cleveland-based developer of new innovative medical devices was awarded a $1 million loan from the state of Ohio that it will use to help commercialize its technology. CardioInsight expects to receive European regulatory clearance in August [...]

CardioInsight Technologies has secured a Japanese distribution partner for its heart-mapping technology, and added about $4 million in investment funding that it hadn’t previously disclosed.

Ohio Third Frontier commissioners made a slew of biomedical grants under two programs today.Recommended for more than $4.9 million under the Ohio Third Frontier Biomedical Program:– CardioX Corp., Dublin, in collaboration with Nottingham-Spirk Design Associates in Cleveland and QTest Labs in Columbus, was awarded $986,373 to finalize designs and clinical protocols for a new method [...]

Steve Arless learned the hard way that it’s never too early to start talking to potential commercial partners that could help develop your early stage medical technology company.Arless told an Ohio Venture Association group on Friday that his decision to pass on an early commercial development offer ended up costing his company a lot more [...]

CardioInsight Technologies has closed its second funding round, raising $6 million from new and existing investors to speed up and expand testing and commercialization of its heart-mapping technology.

CardioInsight Technologies Inc. has raised $5.7 million in an ongoing funding round to help commercialize its heart-mapping technology. The Cleveland company’s electrocardiographic mapping technology could help diagnose and treat electrical abnormalities of the heart, such as heart failure and arrhythmia.